Aastrom Biosciences Sells $25.5 Million In Stock
ANN ARBOR ? Aastrom Biosciences last week said it sold $25.5 million in common stock to a select group of institutional investors. The proceeds will be ussed to fund clinical trials, manufacturing development, and provide working capital, the company said in a statement filed with the U.S. Securities and Exchange Commission. The offering was for